Complete Genomics (GNOM) Continues Run Following Strong LFR Testing Data

July 12, 2012 9:35 AM EDT Send to a Friend
Complete Genomics (Nasdaq: GNOM) is up again in early trading, following a 44 percent run Wednesday on positive LFR Testing data.

Volatility is up slightly in early trade as shares are over 8 percent better.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Insiders' Blog, Momentum Movers

Add Your Comment